SAN JOSE, Calif., Feb. 4, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback